Cover Image

Analysis of a super-transmission of SARS-CoV-2 omicron variant BA.5.2 in the outdoor night market

IntroductionThe COVID-19 pandemic continues to ravage the world, and mutations of the SARS-CoV-2 continues. The new strain has become more transmissible. The role of aerosol transmission in the pandemic deserves great attention.MethodsIn this observational study, we collected data from market custom...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mingyu Luo (Author), Shelan Liu (Author), Liebo Zhu (Author), Fengying Wang (Author), Kunyang Wu (Author), Hanqing He (Author), Xiaohua Qi (Author), Zhifeng Pang (Author), Xuanjun Dong (Author), Zhenyu Gong (Author), Min Yu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Corrigendum: Analysis of a super-transmission of SARS-CoV-2 omicron variant BA.5.2 in the outdoor night market
by: Mingyu Luo, et al.
Published: (2023)

Transmission characteristics of a COVID-19 outbreak caused by Omicron variant BA.5.2 in Yiwu city, China
by: Xiaoxiao WANG, et al.
Published: (2023)

Genomic surveillance of SARS-CoV-2 upsurge in India due to Omicron sub-lineages BA.2.74, BA.2.75 and BA.2.76
by: Urvashi B. Singh, et al.
Published: (2023)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2022)

Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2
by: Weijie Zhong, et al.
Published: (2023)

Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127
by: Chengzhuo Tong, et al.
Published: (2022)

The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
by: Francesca Dapporto, et al.
Published: (2022)

Outcome of Transplant Recipients Infected with Omicron BA.1 and BA.2: A Single-Center Retrospective Study in Saudi Arabia
by: Abeer N. Alshukairi, et al.
Published: (2023)

Epidemiological characteristics of a local COVID-19 outbreak caused by Omicron (BA.2.2) variant in Henan province
by: Jing-jing PAN, et al.
Published: (2022)

An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
by: Meiling Zhang, et al.
Published: (2022)

Association between vaccination status and severe health consequences among community-dwelling COVID-19 patients during Omicron BA.1/BA.2 and BA.5-predominant periods in Japan
by: Kimiko Tomioka, et al.
Published: (2023)

Inactivated vaccine effectiveness against symptomatic COVID-19 in Fujian, China during the Omicron BA.2 outbreak
by: Wenjing Ye, et al.
Published: (2023)

Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
by: Freja Cordelia Møller Kirsebom, et al.
Published: (2022)

Age-specific transmission dynamics under suppression control measures during SARS-CoV-2 Omicron BA.2 epidemic
by: Wenlong Zhu, et al.
Published: (2023)

As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
by: Ren Xu, et al.
Published: (2022)

Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China
by: Wentao Zhu, et al.
Published: (2023)

Real world effectiveness of sotrovimab in preventing COVID-19-related hospitalisation or death in patients infected with Omicron BA.2
by: Alwaleed Behzad, et al.
Published: (2024)

SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil.
by: Francisco P Freire-Neto, et al.
Published: (2022)

Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants
by: Kana Fujimoto, et al.
Published: (2022)

Effectiveness of first and second boost COVID-19 vaccination in healthy adults during BA.5.2/BF.7 surge in China
by: Yongchang Zhang, et al.
Published: (2023)

Corrigendum: Genomic evolution of BA.5.2 and BF.7.14 derived lineages causing SARS-CoV-2 outbreak at the end of 2022 in China
by: Wentao Zhu, et al.
Published: (2024)

Non-covalent cyclic peptides simultaneously targeting Mpro and NRP1 are highly effective against Omicron BA.2.75
by: Shengnan Yin, et al.
Published: (2022)

Covid-19 omicron variant infection in neonates of Guangdong province-a report of 52 cases
by: Yi-Kang Yang, et al.
Published: (2023)

Case report: Severe acute hepatitis in a 22-month-old Chinese boy with Omicron sub-variant BA.2.38
by: Xinying Chen, et al.
Published: (2022)

Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case-control study
by: Xiaqing Zhang, et al.
Published: (2023)

The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan
by: Jih-Jin Tsai, et al.
Published: (2024)

Omicron subvariant BA.5 is highly contagious but containable: Successful experience from Macau
by: Cong Xu, et al.
Published: (2023)

In silico prediction of siRNA to silence the SARS-CoV-2 omicron variant targeting BA.4, BA.5, BQ.1, BQ1.1. and XBB: an alternative to traditional therapeutics
by: Rahatul Islam, et al.
Published: (2023)

Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection
by: Xiaosu Chen, et al.
Published: (2023)

Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
by: Haruka Maeda, et al.
Published: (2023)

Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China
by: Peng Yang, et al.
Published: (2023)

Severity of Omicron BA.5 variant and protective effect of vaccination: national cohort and matched analyses in Scotland
by: Chris Robertson, et al.
Published: (2023)

Multisystem inflammatory syndrome (MIS-C) with SARS-CoV-2 omicron variant BA.2.38 in a four-year-old Chinese girl: A case report
by: Wen-yuan Wang, et al.
Published: (2022)

Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong KongResearch in context
by: Runhong Zhou, et al.
Published: (2023)

Association between exposure to outdoor artificial light at night and the risk of preterm birth
by: Qi Sun, et al.
Published: (2023)

Indoor, outdoor, and night work and blood concentrations of vitamin D and parathyroid hormone
by: Stine Daugaard, et al.
Published: (2018)

Association Between mRNA Vaccination and Infection From SARS-CoV-2 During the Delta and Omicron BA.1 Waves: A Population-Level Analysis
by: Allison P. Plaxco, MPH, et al.
Published: (2023)

Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
by: Alina Seidel, et al.
Published: (2023)

Real-world effectiveness of Yindan Jiedu granules-based treatment on patients infected with the SARS-CoV-2 Omicron variants BA.2 combined with high-risk factors: A cohort study
by: Ying Feng, et al.
Published: (2022)

Night and Morning, Volume 2
by: Lytton, Edward Bulwer Lytton, Baron, 1803-1873